Rating History for Denali Therapeutics Inc. (DNLI) by UBS

More Stocks Rated by UBS | Latest Ratings for DNLI
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/7/2026 Michael Yee New Coverage Buy
(N/A)		 25.00
(N/A)		 16.02
(19.69)		 22.91% Details